Piramal Enterprises has received an approval for scheme of amalgamation for merger of the step-down wholly-owned subsidiaries – PHL Capital, Piramal Pharmaceutical Development Services and Oxygen Bio Research, with itself. The board of directors at its meeting held on May 05, 2014 has approved for the same.
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
0 comments:
Post a Comment